Navigation Links
Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised
Date:7/28/2011

for the third quarter of 2011 in a range of $1.870 billion to $1.970 billion.  Compared to net sales for the third quarter of 2010, this range assumes a $40 million negative impact from the divestiture of the Company’s former Neurovascular business.  The Company estimates earnings on a GAAP basis in a range of $0.03 to $0.08 per share.  Adjusted earnings, excluding acquisition-, divestiture- and restructuring-related net charges and amortization expense, are estimated in a range of $0.11 to $0.14 per share.  Recent acquisitions are expected to dilute third quarter 2011 adjusted earnings by approximately $0.01 per share as compared to the prior year, and the divestiture of the Neurovascular business is expected to dilute third quarter 2011 adjusted earnings by $0.01 per share.

The Company now estimates net sales for the full year 2011 in a range of $7.675 billion to $7.875 billion.  Compared to full year 2010 net sales, this range now assumes a $201 million negative impact from the divestiture of the Neurovascular business.  Recent acquisitions are not expected to contribute to 2011 sales.  The Company now estimates earnings on a GAAP basis in a range of $0.22 to $0.30 per share for the full year 2011.  Adjusted earnings, excluding goodwill and other intangible asset impairment charges; acquisition-, divestiture, and restructuring-related net credits; discrete tax items and amortization expense, are being raised from previous guidance of $0.58 to $0.68 per share to an estimated range of $0.64 to $0.70 per share for the full year 2011.

Conference Call InformationBoston Scientific management will be discussing these results with analysts on a conference call at 8:00 a.m. (ET) today.  The Company will webcast the call to all interested parties through its website at www.bostonscientific.com/investors.  Please visit the website for details o
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine technology :

1. Boston Scientific Announces Five-Year, $150 Million Investment in China to Accelerate Commercial Expansion
2. Boston Scientific to Webcast Conference Call Discussing Second Quarter 2011 Financial Results
3. Boston Scientific Completes Clinical Trial Enrollment for Adapt™ Monorail™ Carotid Stent System
4. Boston Scientific Announces U.S. and European Launch of Interlock™ - 35 Fibered IDC™ Occlusion System
5. Boston Scientific Welcomes Passage of Patent Reform Bill
6. Boston Scientific to Donate $1 Million to ASGEs IT & T Capital Campaign to Build a New State-of-the-Art GI Training Center
7. Boston Scientific Announces Global Launch of Mustang™ PTA Balloon Catheter
8. Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents
9. Boston Scientific Announces Voluntary Recall of iCross™ Coronary Imaging Catheters
10. Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System
11. Boston Heart Lab Changes Name to Boston Heart Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Abaxis, Inc. (NasdaqGS: ABAX ... systems, today reported financial results for the second fiscal ... overview: , Revenues of $53.9 million, up 18% ... of $0.24, up 33% over last year,s comparable quarter. ... Abaxis Veterinary Reference Laboratories (AVRL) of $3.5 million, up ...
(Date:10/22/2014)... Mass. , Oct. 22, 2014 InVivo ... Cambridge, MA is revolutionizing spinal cord injury ... has been shown to outperform in tissue regrowth in ... the scaffold.  Made from an FDA approved polymer, the ... making it harmless to the human body. NVIV has ...
(Date:10/22/2014)... AUSTIN, Texas , Oct. 22, 2014 /PRNewswire/ ... they have entered into a license and collaboration ... target cancers. PhosImmune possesses technology for ... surfaces of tumor cells in association with HLA ... proteins that play a role in malignancy, are ...
Breaking Medicine Technology:Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 2Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 3Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 4Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 5Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 6Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 7Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 8Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 9Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 10Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 11Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 12Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 13Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 14InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2
... April 4, 2011 CarePoint Partners ... Association Annual Conference in Orlando, Florida that it ... infusion therapies including antibiotics, IVIG, nutrition, the associated ... with locations in North Miami and Tampa. This ...
... (Nasdaq: VVUS ) today announced long-term data that ... years showed reductions in blood pressure and the use of ... significant reductions in weight loss as compared to those in ... data – additional results from the SEQUEL study – were ...
Cached Medicine Technology:CarePoint Partners Expands Florida Footprint With Acquisition of Infusion Technologies 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 3
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- Measures taken ... plantation in Ebola-ravaged Liberia may have limited the spread ... researchers report. The Firestone Natural Rubber Co. provides ... and residents of nearby densely populated communities. Between ... and suspected Ebola cases among those 80,000 people. That ...
(Date:10/20/2014)... 2014 The newly updated Worldwide Medical ... thousands of facts, figures and forecasts on the global ... sector forecast categories the Worldwide Medical Market Forecasts ... national views on the worldwide medical market to reveal ... gives you data for 2010-2019, covering each country market ...
(Date:10/20/2014)... 20, 2014 The Advocator Group, ... at the American Foundation for Suicide Prevention’s (AFSP) Out ... is a not-for-profit organization that hosts hundreds of community ... these events are used to help understand and prevent ... personal relationships as well. , The Advocator Group ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 T.E.N., ... relationship-marketing firm, announced today that William H. Murray, ... the 2014 ISE® Luminary Leadership Award winner. Presented ... achievements of an outstanding leader and industry practitioner ... contributions in advancing the information security industry. , ...
(Date:10/20/2014)... Los Angeles, CA (PRWEB) October 20, 2014 ... embodies fitness expertise, nutritional coaching, corporate wellness programming, authorship, ... MS, CPT, is excited to announce the release of ... , After many years of coaching thousands of ... pioneering nutrition tracking app that does not require calorie ...
Breaking Medicine News(10 mins):Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3
... of sexual activity among teens may relate to the ... their childhood, according to a new study released by ... tracking children from age six to eighteen, researchers found ... for adults in television and movies, the earlier they ...
... May 4 Gene Network Sciences, Inc. (GNS) ... Patent No. 7,512,497, entitled "Systems and Methods for ... model learning and simulation platform, REFS(TM) (Reverse Engineering ... in several collaborations with pharmaceutical and biotechnology companies ...
... AMES, Iowa, May 4 Advanced Analytical, based in Ames, ... instrument platform, the DNA PROfiler(TM) system. This ... producing a genetic fingerprint or PROfile. The generated fingerprint ... used for either genus species or strain typing and tracking.Because ...
... May Help Arthritis Sufferers Manage Inflammation and Stiffness ... American adults currently suffer from arthritis - and as ... May has been deemed National Arthritis Month to ... manage associated symptoms. For many with arthritis, one step ...
... in place with GE HealthcareNOIDA, India, May 4 ... announced today that its subsidiary in the United ... Drug Administration (FDA) approval for the Company,s Abbreviated ... The product is found to be bioequivalent and ...
... finds hospital volume to be a useful, albeit imperfect, ... show a quantifiable and statistically significant inverse association between ... studies often fail to show such an association, leading ... imperfect proxy for healthcare quality. , For years, a ...
Cached Medicine News:Health News:Children who view adult-targeted TV may become sexually active earlier in life 2Health News:Gene Network Sciences Awarded Patent Covering REFS(TM) Platform 2Health News:Advanced Analytical Reveals New Platform for Rapid Genotypic Identification of Microorganisms at ASM 2009 2Health News:Experts Recommend Cherries For Pain Relief From Arthritis 2Health News:Experts Recommend Cherries For Pain Relief From Arthritis 3Health News:DRAXIMAGE(R)'s generic Sestamibi Approved for launch in USA 2Health News:DRAXIMAGE(R)'s generic Sestamibi Approved for launch in USA 3Health News:Hospital volume inconsistent predictor of quality care 2
The ZEPHIR Anterior Cervical Plate System is the lowest profile plate clinically available....
... 16 is Philips premium 16-slice CT scanner. ... to automatically delivering high quality, advanced results, the ... a platform that has been the most popular ... comprehensive organ assessment literally within seconds, and with ...
... The PLIF instrument set consists ... conjunction with nerve root protectors, for ... rectangular allograft bone blocks of the ... proper channel preparation which is important ...
... Dilation Port enables the surgeon to perform ... approach using step dilation. Using a series ... aside, creating space for a custom-sized working ... surgeon to operate with a traditional surgical ...
Medicine Products: